Viewing StudyNCT06326502



Ignite Creation Date: 2024-05-06 @ 8:16 PM
Last Modification Date: 2024-10-26 @ 3:24 PM
Study NCT ID: NCT06326502
Status: RECRUITING
Last Update Posted: 2024-03-27
First Post: 2024-03-17

Brief Title: A Safety and Efficacy Study of Multiple Tyrosine Kinase Inhibitor Drug ETN101 in Advanced Hepatocellular Carcinoma
Sponsor: Etnova Therapeutics Corp
Organization: Etnova Therapeutics Corp

Conditions & Keywords Data

Conditions:
Name
Hepatocellular Carcinoma
Advanced Hepatocellular Carcinoma
Liver Cancer
Keywords:
Name View
HCC View